MedPath

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients

Not Applicable
Completed
Conditions
Qt Interval, Variation in
Cardiac Arrhythmia
Interventions
Device: iPhone ECG
Registration Number
NCT02241252
Lead Sponsor
University of Oklahoma
Brief Summary

This study will validate the recording accuracy of a specific electrical interval of the heart, the QT interval, between an iPhone rhythm strip recording and a traditional 12-lead electrocardiogram (ECG). These measurements will occur in hospitalized patients that are starting either sotalol or dofetilide, since both of these medications can prolong the QT interval.

Detailed Description

Patients that were already selected to begin either dofetilide or sotalol in the hospital, will be included in the study. Patients will receive an ECG before and 2 hours after each dose of the medication, which is done to monitor the QT interval. In addition, patients that consent to participate in the study will have an iPhone ECG recording taken in lead positions that correspond to leads I,II, and III.

These recordings will be compared and analyzed to assess the accuracy of the QT interval recordings between the two methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • initiation of sotalol or dofetilide
  • inpatient at University hospital
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
iPhone ECG QT recordingiPhone ECGiPhone ECG
Primary Outcome Measures
NameTimeMethod
QT interval measurement (in milliseconds)Participants will be followed for duration of hospital stay during which dofetilide or sotalol are being started, an expected average of 3 days

The QT interval (measured from the start of the QRS to the end of the T wave) will be measured on the 12-lead ECG and on the iPhone rhythm strip recording. Both measurements will be recorded in milliseconds and will be statistically analyzed for bias and agreement.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath